推薦產品
等級
anhydrous
品質等級
化驗
≥98%
形狀
powder
mp
295 °C (dec.) (lit.)
SMILES 字串
CN1CC(=O)N=C1N
InChI
1S/C4H7N3O/c1-7-2-3(8)6-4(7)5/h2H2,1H3,(H2,5,6,8)
InChI 密鑰
DDRJAANPRJIHGJ-UHFFFAOYSA-N
尋找類似的產品？ 前往 產品比較指南
一般說明
肌酐是在肌肉来源的磷酸肌酸降解过程中产生的分解产物。几乎所有肌酐都由肾脏从血液中滤过并排到尿液中，从而排出体外。血清肌酐是肾功能的最常用指标。在化学合成中，肌酐作为杂环含氮化合物，可产生富电子和强碱性肌酐衍生物。
應用
肌酐可用于：
- 作为氮供体构筑块(building block)制备含氮杂环衍生物。
- 作为反应剂合成供体-受体氮化碳共聚物，该共聚物可用作制氢光催化剂。
- 作为起始材料经由肌酐氯胺的形成制备creatol（肌酐醇）(2-氨基-1,5-二氢-5-羟甲基咪唑-4-酮)。
- 作为反应剂与各种靛红通过金催化的羟醛化作用合成3-取代-3-羟基靛红。
儲存類別代碼
13 - Non Combustible Solids
水污染物質分類（WGK）
WGK 3
閃點（°F）
554.0 °F - closed cup
閃點（°C）
290 °C - closed cup
個人防護裝備
Eyeshields, Gloves, type N95 (US)
客戶也查看了
Study of Creatinine and its 5-Alkoxy Analogs: Structure and Conformational Studies in the Solid and Solution States by X-Ray Crystallography, NMR, UV and Mass Spectrometry
Arakali AV, et al.
Nucleosides, nucleotides & nucleic acids, 16(12), 2193-2218 (1997)
A Simple Conversion of Creatinine to Creatol via Creatinine Chloroamine
Ienaga K, et al.
Australian Journal of Chemistry, 68(2), 248-253 (2015)
Karel G M Moons et al.
Annals of internal medicine, 162(1), W1-73 (2015-01-07)
The TRIPOD (Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis) Statement includes a 22-item checklist, which aims to improve the reporting of studies developing, validating, or updating a prediction model, whether for diagnostic or prognostic purposes.
Richard E Gilbert et al.
Diabetologia, 57(7), 1325-1331 (2014-04-29)
As glycaemia and the incidence of microvascular diabetes complications follow a log-linear relationship, it becomes increasingly difficult to demonstrate a microvascular benefit of glucose-lowering when the HbA1c level is close to normal. The Outcome Reduction with an Initial Glargine Intervention
Norishige Yoshikawa et al.
Kidney international, 87(1), 225-232 (2014-07-24)
In this multicenter, open-label, randomized controlled trial, we determined whether 2-month prednisolone therapy for steroid-sensitive nephrotic syndrome was inferior or not to 6-month therapy despite significantly less steroid exposure. The primary end point was time from start of initial treatment
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務